CORBION NV (CRBN.AS) Fundamental Analysis & Valuation

AMS:CRBN • NL0010583399

18.85 EUR
-0.16 (-0.84%)
Last: Mar 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This CRBN.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

CRBN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 66 industry peers in the Chemicals industry. CRBN has an average financial health and profitability rating. CRBN is valued quite cheap, but it does not seem to be growing. With these ratings, CRBN could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

6

1. CRBN.AS Profitability Analysis

1.1 Basic Checks

  • CRBN had positive earnings in the past year.
  • In the past year CRBN had a positive cash flow from operations.
  • CRBN had positive earnings in each of the past 5 years.
  • In the past 5 years CRBN always reported a positive cash flow from operatings.
CRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFCRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

  • CRBN has a Return On Assets of 4.57%. This is in the better half of the industry: CRBN outperforms 66.67% of its industry peers.
  • Looking at the Return On Equity, with a value of 9.14%, CRBN is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
  • CRBN has a Return On Invested Capital of 9.22%. This is in the better half of the industry: CRBN outperforms 72.73% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CRBN is in line with the industry average of 6.96%.
  • The last Return On Invested Capital (9.22%) for CRBN is above the 3 year average (6.62%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.57%
ROE 9.14%
ROIC 9.22%
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
CRBN.AS Yearly ROA, ROE, ROICCRBN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • CRBN's Profit Margin of 5.12% is fine compared to the rest of the industry. CRBN outperforms 62.12% of its industry peers.
  • CRBN's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 8.70%, CRBN is in the better half of the industry, outperforming 62.12% of the companies in the same industry.
  • CRBN's Operating Margin has declined in the last couple of years.
  • The Gross Margin of CRBN (26.10%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of CRBN has declined.
Industry RankSector Rank
OM 8.7%
PM (TTM) 5.12%
GM 26.1%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
CRBN.AS Yearly Profit, Operating, Gross MarginsCRBN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CRBN.AS Health Analysis

2.1 Basic Checks

  • CRBN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for CRBN has been reduced compared to 1 year ago.
  • The number of shares outstanding for CRBN has been reduced compared to 5 years ago.
  • CRBN has a better debt/assets ratio than last year.
CRBN.AS Yearly Shares OutstandingCRBN.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CRBN.AS Yearly Total Debt VS Total AssetsCRBN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 2.77 indicates that CRBN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.77, CRBN is in the better half of the industry, outperforming 62.12% of the companies in the same industry.
  • CRBN has a debt to FCF ratio of 4.92. This is a neutral value as CRBN would need 4.92 years to pay back of all of its debts.
  • The Debt to FCF ratio of CRBN (4.92) is better than 69.70% of its industry peers.
  • A Debt/Equity ratio of 0.39 indicates that CRBN is not too dependend on debt financing.
  • CRBN has a Debt to Equity ratio of 0.39. This is comparable to the rest of the industry: CRBN outperforms 57.58% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.92
Altman-Z 2.77
ROIC/WACC1.44
WACC6.38%
CRBN.AS Yearly LT Debt VS Equity VS FCFCRBN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 1.21 indicates that CRBN should not have too much problems paying its short term obligations.
  • CRBN's Current ratio of 1.21 is on the low side compared to the rest of the industry. CRBN is outperformed by 75.76% of its industry peers.
  • CRBN has a Quick Ratio of 1.21. This is a bad value and indicates that CRBN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CRBN's Quick ratio of 0.60 is on the low side compared to the rest of the industry. CRBN is outperformed by 86.36% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.6
CRBN.AS Yearly Current Assets VS Current LiabilitesCRBN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CRBN.AS Growth Analysis

3.1 Past

  • The earnings per share for CRBN have decreased strongly by -68.92% in the last year.
  • The Earnings Per Share has been growing by 49.47% on average over the past years. This is a very strong growth
  • CRBN shows a small growth in Revenue. In the last year, the Revenue has grown by 2.95%.
  • The Revenue has been growing slightly by 5.70% on average over the past years.
EPS 1Y (TTM)-68.92%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.24% on average over the next years. This is quite good.
  • The Revenue is expected to decrease by -1.71% on average over the next years.
EPS Next Y36.96%
EPS Next 2Y22.71%
EPS Next 3Y19.54%
EPS Next 5Y15.24%
Revenue Next Year-2.78%
Revenue Next 2Y-0.53%
Revenue Next 3Y0.84%
Revenue Next 5Y-1.71%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRBN.AS Yearly Revenue VS EstimatesCRBN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B
CRBN.AS Yearly EPS VS EstimatesCRBN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

7

4. CRBN.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 16.83 indicates a correct valuation of CRBN.
  • 72.73% of the companies in the same industry are more expensive than CRBN, based on the Price/Earnings ratio.
  • CRBN is valuated rather cheaply when we compare the Price/Earnings ratio to 26.29, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 12.44, CRBN is valued correctly.
  • CRBN's Price/Forward Earnings ratio is rather cheap when compared to the industry. CRBN is cheaper than 83.33% of the companies in the same industry.
  • CRBN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.57, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.83
Fwd PE 12.44
CRBN.AS Price Earnings VS Forward Price EarningsCRBN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CRBN is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, CRBN is valued cheaper than 93.94% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.94
EV/EBITDA 7.91
CRBN.AS Per share dataCRBN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of CRBN may justify a higher PE ratio.
  • CRBN's earnings are expected to grow with 19.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.46
PEG (5Y)0.34
EPS Next 2Y22.71%
EPS Next 3Y19.54%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. CRBN.AS Dividend Analysis

5.1 Amount

  • CRBN has a Yearly Dividend Yield of 3.12%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 2.21, CRBN pays a bit more dividend than its industry peers.
  • CRBN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.12%

5.2 History

  • The dividend of CRBN has a limited annual growth rate of 5.02%.
Dividend Growth(5Y)5.02%
Div Incr Years1
Div Non Decr Years5
CRBN.AS Yearly Dividends per shareCRBN.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • CRBN pays out 56.02% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • CRBN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP56.02%
EPS Next 2Y22.71%
EPS Next 3Y19.54%
CRBN.AS Yearly Income VS Free CF VS DividendCRBN.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M
CRBN.AS Dividend Payout.CRBN.AS Dividend Payout, showing the Payout Ratio.CRBN.AS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CRBN.AS Fundamentals: All Metrics, Ratios and Statistics

CORBION NV

AMS:CRBN (3/6/2026, 7:00:00 PM)

18.85

-0.16 (-0.84%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-26
Earnings (Next)N/A
Inst Owners92.92%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap1.10B
Revenue(TTM)1.30B
Net Income(TTM)66.40M
Analysts78.57
Price Target24.12 (27.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.12%
Yearly Dividend0.71
Dividend Growth(5Y)5.02%
DP56.02%
Div Incr Years1
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.85%
PT rev (3m)3.39%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.26%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.38%
Revenue NY rev (3m)-0.99%
Valuation
Industry RankSector Rank
PE 16.83
Fwd PE 12.44
P/S 0.85
P/FCF 10.94
P/OCF 6.51
P/B 1.51
P/tB 1.73
EV/EBITDA 7.91
EPS(TTM)1.12
EY5.94%
EPS(NY)1.52
Fwd EY8.04%
FCF(TTM)1.72
FCFY9.14%
OCF(TTM)2.9
OCFY15.36%
SpS22.26
BVpS12.47
TBVpS10.88
PEG (NY)0.46
PEG (5Y)0.34
Graham Number17.72
Profitability
Industry RankSector Rank
ROA 4.57%
ROE 9.14%
ROCE 10.95%
ROIC 9.22%
ROICexc 9.59%
ROICexgc 10.58%
OM 8.7%
PM (TTM) 5.12%
GM 26.1%
FCFM 7.74%
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
ROICexc(3y)7.16%
ROICexc(5y)7.83%
ROICexgc(3y)8.31%
ROICexgc(5y)9.44%
ROCE(3y)7.87%
ROCE(5y)8.47%
ROICexgc growth 3Y0.82%
ROICexgc growth 5Y-11.84%
ROICexc growth 3Y3.78%
ROICexc growth 5Y-8.06%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
F-Score6
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.92
Debt/EBITDA 1.43
Cap/Depr 80.83%
Cap/Sales 5.27%
Interest Coverage 7.23
Cash Conversion 85.5%
Profit Quality 151.21%
Current Ratio 1.21
Quick Ratio 0.6
Altman-Z 2.77
F-Score6
WACC6.38%
ROIC/WACC1.44
Cap/Depr(3y)194.04%
Cap/Depr(5y)192.31%
Cap/Sales(3y)11.51%
Cap/Sales(5y)11.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.92%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
EPS Next Y36.96%
EPS Next 2Y22.71%
EPS Next 3Y19.54%
EPS Next 5Y15.24%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%
Revenue Next Year-2.78%
Revenue Next 2Y-0.53%
Revenue Next 3Y0.84%
Revenue Next 5Y-1.71%
EBIT growth 1Y54.95%
EBIT growth 3Y8.15%
EBIT growth 5Y1.31%
EBIT Next Year128.69%
EBIT Next 3Y37.25%
EBIT Next 5Y26.73%
FCF growth 1Y172.18%
FCF growth 3YN/A
FCF growth 5Y21.2%
OCF growth 1Y119.09%
OCF growth 3Y101.81%
OCF growth 5Y9.98%

CORBION NV / CRBN.AS FAQ

What is the fundamental rating for CRBN stock?

ChartMill assigns a fundamental rating of 5 / 10 to CRBN.AS.


What is the valuation status of CORBION NV (CRBN.AS) stock?

ChartMill assigns a valuation rating of 7 / 10 to CORBION NV (CRBN.AS). This can be considered as Undervalued.


What is the profitability of CRBN stock?

CORBION NV (CRBN.AS) has a profitability rating of 6 / 10.


What is the earnings growth outlook for CORBION NV?

The Earnings per Share (EPS) of CORBION NV (CRBN.AS) is expected to grow by 36.96% in the next year.


How sustainable is the dividend of CORBION NV (CRBN.AS) stock?

The dividend rating of CORBION NV (CRBN.AS) is 6 / 10 and the dividend payout ratio is 56.02%.